Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
145 | Clinical and Translational Medicine | journal | 2.424 Q1 | 18 | 0 | 96 | 0 | 546 | 47 | 5.69 | 0.00 | |
144 | Drug Discovery Today: Disease Models | journal | 0.665 Q3 | 33 | 0 | 23 | 0 | 64 | 20 | 0.00 | 0.00 | |
143 | Drug Discovery Today: Technologies | journal | 1.241 Q1 | 62 | 0 | 53 | 0 | 295 | 48 | 3.50 | 0.00 | |
142 | Forum on Immunopathological Diseases and Therapeutics | journal | 0.104 Q4 | 14 | 0 | 9 | 0 | 0 | 9 | 0.00 | 0.00 | |
141 | Journal of Stem Cells | journal | 0.101 Q4 | 21 | 0 | 32 | 0 | 0 | 31 | 0.00 | 0.00 | |
140 | Pteridines | journal | 0.175 Q4 | 19 | 2 | 43 | 83 | 22 | 42 | 0.54 | 41.50 | |
139 | Frontiers in Anti-infective Drug Discovery | book series | 0.209 Q4 | 3 | 1 | 7 | 124 | 3 | 1 | 0.17 | 124.00 | |
138 | Molecular and Cellular Oncology | journal | 0.471 Q3 | 37 | 4 | 244 | 155 | 237 | 156 | 0.88 | 38.75 | |
137 | Expert Review of Precision Medicine and Drug Development | journal | 0.257 Q4 | 16 | 3 | 102 | 251 | 92 | 79 | 0.90 | 83.67 | |
136 | MCB Molecular and Cellular Biomechanics | journal | 0.315 Q4 | 31 | 10 | 59 | 382 | 76 | 59 | 1.60 | 38.20 | |
135 | Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | journal | 0.168 Q4 | 16 | 12 | 118 | 408 | 61 | 118 | 0.59 | 34.00 | |
134 | Biomarker Insights | journal | 0.974 Q2 | 40 | 9 | 67 | 468 | 246 | 59 | 3.34 | 52.00 | |
133 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.688 Q3 | 29 | 7 | 21 | 562 | 185 | 7 | 10.64 | 80.29 | |
132 | Eurobiotech Journal | journal | 0.236 Q4 | 10 | 13 | 64 | 573 | 93 | 63 | 1.30 | 44.08 | |
131 | Molecular Imaging | journal | 0.514 Q3 | 66 | 9 | 60 | 606 | 128 | 60 | 1.97 | 67.33 | |
130 | Cell Stress | journal | 1.852 Q1 | 27 | 12 | 67 | 632 | 350 | 67 | 3.53 | 52.67 | |
129 | Turkish Computational and Theoretical Chemistry | journal | 0.191 Q4 | 8 | 17 | 30 | 667 | 43 | 30 | 0.89 | 39.24 | |
128 | European Journal of Hybrid Imaging | journal | 0.479 Q3 | 14 | 28 | 87 | 773 | 183 | 87 | 1.73 | 27.61 | |
127 | Pharmacogenetics and Genomics | journal | 0.563 Q3 | 152 | 25 | 97 | 907 | 208 | 95 | 1.94 | 36.28 | |
126 | Cellular Therapy and Transplantation | journal | 0.170 Q4 | 8 | 32 | 90 | 970 | 26 | 88 | 0.25 | 30.31 | |
125 | OBM Genetics | journal | 0.160 Q4 | 4 | 16 | 68 | 973 | 21 | 63 | 0.38 | 60.81 | |
124 | Cold Spring Harbor molecular case studies | journal | 0.801 Q2 | 25 | 38 | 190 | 1110 | 337 | 189 | 1.80 | 29.21 | |
123 | Pharmacogenomics Journal | journal | 0.659 Q3 | 95 | 28 | 194 | 1215 | 524 | 193 | 2.58 | 43.39 | |
122 | Blood Cells, Molecules, and Diseases | journal | 0.584 Q3 | 98 | 32 | 192 | 1217 | 313 | 154 | 1.65 | 38.03 | |
121 | Molecular Cytogenetics | journal | 0.403 Q4 | 38 | 36 | 160 | 1356 | 225 | 159 | 1.43 | 37.67 | |
120 | Assay and Drug Development Technologies | journal | 0.317 Q4 | 65 | 32 | 126 | 1530 | 234 | 118 | 1.61 | 47.81 | |
119 | Nucleic Acid Therapeutics | journal | 1.252 Q1 | 77 | 33 | 125 | 1583 | 502 | 122 | 3.95 | 47.97 | |
118 | Turkish Journal of Pharmaceutical Sciences | journal | 0.364 Q4 | 22 | 50 | 289 | 1621 | 625 | 279 | 2.09 | 32.42 | |
117 | Nuclear Medicine and Biology | journal | 0.658 Q3 | 98 | 42 | 210 | 1676 | 603 | 200 | 3.15 | 39.90 | |
116 | Extremophiles | journal | 0.726 Q3 | 95 | 29 | 151 | 1759 | 465 | 151 | 2.51 | 60.66 | |
115 | Personalized Medicine | journal | 0.412 Q3 | 36 | 43 | 146 | 1840 | 255 | 138 | 1.62 | 42.79 | |
114 | Journal of Experimental Pharmacology | journal | 0.778 Q2 | 23 | 41 | 153 | 1868 | 578 | 152 | 3.76 | 45.56 | |
113 | FASEB BioAdvances | journal | 0.764 Q2 | 18 | 40 | 210 | 1940 | 560 | 202 | 2.52 | 48.50 | |
112 | European Journal of Medicinal Chemistry Reports | journal | 0.588 Q3 | 11 | 22 | 86 | 1972 | 367 | 86 | 4.27 | 89.64 | |
111 | SLAS Discovery | journal | 0.869 Q2 | 33 | 59 | 289 | 2627 | 828 | 269 | 2.86 | 44.53 | |
110 | Future Cardiology | journal | 0.412 Q4 | 43 | 85 | 312 | 2646 | 422 | 298 | 1.40 | 31.13 | |
109 | Advances in Biological Regulation | journal | 1.114 Q2 | 69 | 39 | 111 | 2651 | 395 | 105 | 2.77 | 67.97 | |
108 | SAR and QSAR in Environmental Research | journal | 0.359 Q4 | 54 | 49 | 147 | 2680 | 414 | 147 | 2.58 | 54.69 | |
107 | Molecular Informatics | journal | 0.550 Q3 | 75 | 54 | 172 | 2684 | 517 | 167 | 2.90 | 49.70 | |
106 | NeuroMolecular Medicine | journal | 1.001 Q2 | 82 | 52 | 146 | 2913 | 554 | 145 | 3.76 | 56.02 | |
105 | Molecular Pharmacology | journal | 1.038 Q2 | 210 | 58 | 276 | 2954 | 801 | 269 | 2.59 | 50.93 | |
104 | Journal of Natural Medicines | journal | 0.685 Q3 | 59 | 95 | 285 | 2958 | 1010 | 263 | 2.84 | 31.14 | |
103 | Journal of Pharmacological Sciences | journal | 0.876 Q2 | 101 | 80 | 324 | 3004 | 1106 | 324 | 3.23 | 37.55 | |
102 | Journal of Molecular Diagnostics | journal | 1.265 Q1 | 111 | 88 | 419 | 3113 | 1541 | 405 | 3.32 | 35.38 | |
101 | Function | journal | 0.987 Q2 | 16 | 74 | 173 | 3180 | 401 | 136 | 2.18 | 42.97 | |
100 | Clinical Proteomics | journal | 1.015 Q2 | 42 | 55 | 117 | 3191 | 442 | 113 | 2.81 | 58.02 | |
99 | Molecular Pain | journal | 0.904 Q2 | 96 | 60 | 203 | 3203 | 663 | 202 | 2.74 | 53.38 | |
98 | AIDS Research and Therapy | journal | 0.872 Q2 | 49 | 89 | 234 | 3234 | 555 | 234 | 2.18 | 36.34 | |
97 | Journal of Experimental Zoology Part B: Molecular and Developmental Evolution | journal | 0.781 Q2 | 70 | 58 | 169 | 3259 | 314 | 141 | 1.66 | 56.19 | |
96 | Drugs in Context | journal | 0.811 Q2 | 36 | 58 | 193 | 3370 | 574 | 193 | 2.46 | 58.10 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®